News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom Michael O'Riordan February 09, 2024
News Daily News FDA Approves First Transcatheter Tricuspid Valve Replacement Device L.A. McKeown February 02, 2024